Speakers

Garry Neil, MD
Corporate Vice President
Corporate Office of Science & Technology
Johnson & Johnson

Garry has broad experience in the science, medicine and pharmaceutical development. He has held a number of senior positions within J&J, most recently Group President, Johnson and Johnson Pharmaceutical Research and Development where he was responsible for maximizing existing strengths and leveraging collective resources to bring innovative new molecular entities (NMEs) to market quickly and cost effectively .  Through a number of new initiatives he helped transform J&J's pharmaceutical R&D to a much more capable and productive organization and helped recruit a number of top scientists. Under his leadership a number of important new medicines for the treatment of cancer, anemia, infections, central nervous system and psychiatric disorders, pain, and genitourinary and gastrointestinal diseases, gained initial or new and/or expanded indication approvals.

Garry joined J&J in 2002 as Senior Vice President of Drug Development at Johnson & Johnson Pharmaceutical Research and Development (J&JPRD). In 2005, Garry became President of J&JPRD, and in 2006, was promoted to Group President. Before joining J&JPRD, he held senior-level positions with Astra Merck Inc.

Garry has written more than 50 articles and book chapters. He holds a Bachelor of Science degree from the University of Saskatchewan and a medical degree from the University of Saskatchewan College of Medicine and completed his postdoctoral clinical training in internal medicine and gastroenterology at the University of Toronto. He also completed a postdoctoral research fellowship at the Research Institute of Scripps Clinic. He is a Fellow of the American College of Physicians, a Fellow of the American College of Gastroenterology, a member of the American Association of Immunologists, and the Society for Clinical Trials. He is a member of the Board of the Reagan Udall Foundation, the J&J Development Corporation and is J&J's representative to, and Vice Chairman, of the Pharmaceutical Research and Manufacturers Association (PhRMA) Science and Regulatory Committee, Vice Chairman and Treasurer of the PhRMA Foundation Board, a member of the Board of Trustees for the Robert Wood Johnson Medical School, a member of the Scientific Advisory Board of the Center for Advanced Biotechnology and Medicine (Rutgers), a member of the Executive Committee of the Biomarkers Consortium, and a member of the Board of Trustees of the Newark Boys Chorus School. He is also the 2007 discovery awardee of the American Geriatrics Society.